ECL1i is an allosteric and selective CCR2 inhibitor. It specifically suppresses CCL2-/CCR2-mediated chemotaxis. ECL1i can disrupt the recruitment of CCR2-positive cells and alleviate the progression of experimental autoimmune encephalomyelitis.
Molecular Weight:
780.98
CAS Number:
[1417312-35-6]
Formula:
C36H60N8O9S
Target:
CCR
* VAT and and shipping costs not included. Errors and price changes excepted
